MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2019 International Congress

    Quantitative EEG measures reflect general cognitive status in Parkinson’s disease

    C. Navarro-Roa, M. Rodriguez-Violante, G. Sanchez-Dinorin, A. Cervantes-Arriaga, R. Solis-Vivanco (Mexico City, Mexico)

    Objective: To explore the utility of the quantitative electroencephalogram (EEG) as a potential biomarker of cognitive status in patients with Parkinson's disease (PD). Background: While…
  • 2019 International Congress

    Cognitive Training in Parkinson’s Disease: Experience in a Rehabilitation Hospital from Brazil

    N. Sousa, A. Neri, I. Brandi, S. Brucki (Salvador, Brazil)

    Objective: To determine the impact of cognitive training (CT) on cognitive and quality of life measures in patients with Parkinson's Disease (PD). Background: PD is…
  • 2019 International Congress

    Cognitive Processes That Indirectly Effect Olfactory Dysfunction in Parkinson’s Disease

    B. Chase, A. Mertens, J. Santo, K. Markopoulou (Omaha, NE, USA)

    Objective: Investigate cognitive mechanisms contributing to olfactory dysfunction in Parkinson’s disease. Background: Accurate early diagnosis of Parkinson’s disease is hampered by its long prodromal period…
  • 2019 International Congress

    Primary disruption of the subsystems of the default mode network in drug-naïve Parkinson’s disease with mild cognitive impairments: a resting-state functional connectivity MRI study

    YB. Hou, QQ. Wei, RW. Ou, J. Yang, W. Song, QY. Gong, HF. Shang (Chengdu, China)

    Objective: To study changes in subsystems in drug-naïve Parkinson’s disease with mild cognitive impairments using resting-state functional connectivity MRI. Background: Mild cognitive impairment (MCI) is common…
  • 2019 International Congress

    Seeking regulatory feedback on novel clinical outcome assessments: a case example from the Huntington’s Disease – Regulatory Science Consortium (HD-RSC)

    A. Mullin, R. Fuller, G. Stebbins, J. Stout, A. Robbins, P. Feigenbaum, M. Roche, E. Gantman, C. Sampaio, M. Brumfield (Tucson, AZ, USA)

    Objective: To align with regulators on the utility and development strategy of novel clinical outcome assessments for use in Huntington’s disease (HD) clinical trials. Background:…
  • 2019 International Congress

    Efficacy of Motor Imagery Questionnaire-RS as a Diagnostic Tool in Rehabilitation of Movement Disorders

    D. Kaur, N. Bhardwaj, S. Kumari, S. Kumari, A. Gupta, G. Kumar (Patna, India)

    Objective: The present study attempts to establish the normative reference value for motor imagery and compare it with patients with movement disorders. Background: Motor imagery,…
  • 2019 International Congress

    Cognitive event related potentials as biomarker of non-motor phenotypes in Parkinson’s Disease

    N. Koshel, S. Kryzhanovskyi, N. Karasevych, A. Pisaruk, I. Karaban (Kyiv, Ukraine)

    Objective: This research aimed to study the specific changes in cognitive event related potentials (ERP) in patients with different non-motor subtypes of Parkinson’s disease (PD).…
  • 2019 International Congress

    Puzzle resolution as cognitive test in Parkinson´s disease patients

    C. Borrue-Fernandez, D. Santos-García, J. Pagonabarraga, B. Pascual-Sedano, M. Mata, C. Study Group (Madrid, Spain)

    Objective: To analyze the value of puzzle resolution for cognitive testing in Parkinson´s disease patients. Background: Cognitive decline and dementia are common among Parkinson disease…
  • 2019 International Congress

    The Effects of Time-Varying Caloric Vestibular Stimulation Therapy on Cognition Impairment in Parkinson’s Disease

    K. Ade, A. Podlewska, S. Banducci, T. Pellat-Higgins, M. Bodani, M. Sakel, L. Smith, D. Attix, P. Lewitt, D. Wilkinson (Raleigh, NC, USA)

    Objective: To evaluate the potential efficacy of a software-controlled, solid-state, time-varying caloric vestibular stimulation (tvCVS) device for the treatment of cognitive impairment in Parkinson’s disease…
  • 2019 International Congress

    Semantic fluency impairment and amygdala atrophy are predictive factors for the development of Parkinson’s disease dementia

    O. Cousins, G. Pagano, J. Schulz, G. Dervenoulas, H. Wilson, S. Caminiti, S. Polychronis, M. Politis (London, United Kingdom)

    Objective: We investigated neuroanatomical differences between Parkinson’s disease (PD) patients with and without semantic fluency impairment and explored predictive markers for dementia development. Background: Sematic…
  • « Previous Page
  • 1
  • …
  • 66
  • 67
  • 68
  • 69
  • 70
  • …
  • 117
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley